Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Email previous post Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Should You Invest in Silver Bullion? June 6, 2025 Trump Admin Strips “Safety” from AI Oversight Institute... June 6, 2025 In-fill RC Drilling at Kamperman Confirms High-Grade Gold June 6, 2025 Offer Booklet – Non-Renounceable Entitlement Offer June 6, 2025 Justin Huhn: Uranium Game On — Supply “Mirage,”... June 6, 2025 Scoping Study Demonstrates Low Cost ISR Uranium Potential June 5, 2025 Satellite Imagery and Gold Exploration June 5, 2025 Victoria Gold-Silver Exploration Update June 5, 2025 Finlay Minerals Announces Increase in Size of Non-Brokered... June 5, 2025 Scoping Study Demonstrates Low Cost Potential (Replacement) June 5, 2025